Wesley Merritt, MD
Anesthesiology · Allen, TXNPI 1396700571
Payments from drug & device makers
Across 111 payments — averaging $19.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$954
- Arbor Pharmaceuticals, Inc.$454
- AbbVie$128
- Boston Scientific$112
- Azurity Pharmaceuticals, Inc.$69
- Biohaven Pharmaceuticals, Inc.$69
- plus $421 from 15 others
What the payments were for
- Food & beverage$1,862100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 35 | $954 |
| Arbor Pharmaceuticals, Inc. | 33 | $454 |
| AbbVie(2 entities) | 8 | $128 |
| Boston Scientific | 6 | $112 |
| Azurity Pharmaceuticals, Inc. | 4 | $69 |
| Biohaven Pharmaceuticals, Inc. | 4 | $69 |
| Assertio Therapeutics, Inc. | 3 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $53 |
| Novartis | 2 | $49 |
| Abbott | 2 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Vertiflex, Inc. | 1 | $27 |
| Averitas Pharma Inc. | 1 | $23 |
| Trevena, Inc. | 1 | $22 |
| Redhill Biopharma Inc. | 1 | $21 |
| Virtus Pharmaceuticals LLC | 1 | $19 |
| Amgen | 1 | $15 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Avanos Medical | 1 | $13 |
| IBSA Pharma Inc. | 1 | $12 |
How this compares
$2,207 in reported general payments places this provider in the 90th percentile of 3,899 anesthesiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Piroxicam | 14 | $7,980 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 119 | $4,624 |
| Calcipotriene | 13 | $3,747 |
| Amitriptyline Hcl | 82 | $2,832 |
| Gabapentin | 95 | $2,462 |
| Methadone Hcl | 111 | $1,587 |
| Methocarbamol | 57 | $1,498 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 62 | $1,476 |
| Baclofen | 24 | $1,280 |
| Pregabalin | 22 | $909 |
| Morphine Sulfate ErMorphine Sulfate | 36 | $865 |
| Tramadol Hcl | 51 | $825 |
| Diclofenac Sodium | 28 | $767 |
| Oxycodone Hcl | 41 | $746 |
| Tizanidine Hcl | 46 | $662 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Allen
- Daneshvar SolankiLeague City$38M
- David BrownHouston$2.5M
- Holger EltzschigHouston$1.6M
- Julie GreeneFort Worth$1.1M
- Maria MatuszczakHouston$907K
- Ryan CaseyAustin$844K
- Richard TeamesFort Worth$746K
- Tong GanHouston$703K
- Valentine GibsonRichardson$671K
- James MuellerDallas$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.